Methotrexate and Joint Pain: What the Numbers Say

Recent research has taken a close look at how methotrexate, a drug most known for treating rheumatoid arthritis, might help people with osteoarthritis. Osteoarthritis is the common joint problem that wears down cartilage and causes pain, especially in older adults. Doctors have long searched for medicines that can slow this damage, but options are limited. One way to judge a medicine’s value is by examining many studies together. The new review pulled data from dozens of clinical trials and compared the outcomes of patients who received methotrexate with those who did not. The combined evidence showed a modest improvement in pain relief and joint function, but the effect was small compared with stronger drugs used for rheumatoid arthritis.The researchers also examined whether methotrexate might affect nutrition. Because the drug can interfere with folic acid metabolism, it could potentially lead to vitamin deficiencies or anemia. The pooled data indicated a slight increase in low folate levels, yet most patients tolerated the medication well when supplemented with folic acid. No major safety concerns emerged from the analysis. Beyond the numbers, the study highlights a gap in knowledge. Many of the included trials were short‑term and had small sample sizes, making it hard to draw firm conclusions about long‑term safety or disease modification. Future research should focus on larger, longer studies that monitor both clinical outcomes and nutritional status. In short, methotrexate may offer a small benefit for osteoarthritis pain, but its role remains uncertain. Patients and clinicians should weigh the modest advantages against potential nutrient effects and consider alternative treatments while awaiting clearer evidence.